Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients

Journal of Clinical Psychopharmacology
Mitchell J BarnettPeter J Kaboli

Abstract

To evaluate the use of typical and atypical antipsychotic medications and associated in-hospital mortality in a group of Veterans Administration (VA) patients with pneumonia. Our cohort consisted of 14,057 VA patients admitted for pneumonia in fiscal year (FY) 2003. Exposure to typical and atypical antipsychotics and other neuropsychiatric drugs was based on a prescription within 120 days preceding admission. Multivariate models determined the odds of mortality associated with each drug class and risk adjusted for comorbidity, admission source, demographic factors, and concurrent mental health conditions. The referent group for each analysis was pneumonia patients not receiving neuropsychiatric drugs. In adjusted analyses, the odds of in-hospital mortality for VA patients admitted with pneumonia was higher for recent exposure to typical antipsychotics (OR = 1.51, 95% CI = 1.04-2.19; P = 0.03) when compared to patients not receiving neuropsychiatric medications. Patients exposed to atypical antipsychotics (OR = 1.20, 95% CI = 0.96-1.50, P = .10), tricyclic antidepressants (OR = 1.20, 95% CI = 0.44-1.55; P = 0.15), other antidepressants (OR = 1.07, 95% CI = 0.93-1.23; P = 0.37), or mood stabilizers (OR = 0.91, 95% CI = 0.73-1.14;...Continue Reading

References

May 1, 1993·The American Review of Respiratory Disease·H E GreenbergH Green
Nov 25, 1997·JAMA : the Journal of the American Medical Association·L I Iezzoni
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Dec 26, 2001·Archives of General Psychiatry·W A RayK T Murray
Mar 13, 2002·Inquiry : a Journal of Medical Care Organization, Provision and Financing·L M Lamers
Nov 27, 2002·Journal of Affective Disorders·Pim Cuijpers, Filip Smit
Jan 25, 2003·Journal of Clinical Psychopharmacology·Harry J WitchelDavid J Nutt
Jan 14, 2004·The Journal of Nervous and Mental Disease·Cheryl EngerAlexander M Walker
Feb 7, 2004·Pharmacoepidemiology and Drug Safety·Lianne ParkinCharlotte Paul
Apr 24, 2004·Annals of General Hospital Psychiatry·Kimberly D McLaren, Lauren B Marangell
Jul 1, 2004·Archives of Internal Medicine·Sabine M J M StrausBruno H C Stricker
Aug 3, 2004·The American Journal of Psychiatry·Stephen R MarderSteven Shon
Sep 24, 2004·Bipolar Disorders·Amy M KilbourneGretchen L Haas
Nov 27, 2004·Psychosomatic Medicine·Jürgen BarthChristoph Herrmann-Lingen
Dec 1, 2004·Stroke; a Journal of Cerebral Circulation·Brooks B GumpUNKNOWN MRFIT Research Group
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Peter V Rabins, Constantine G Lyketsos

❮ Previous
Next ❯

Citations

Mar 12, 2011·Current Infectious Disease Reports·Gianluca Trifirò
Feb 27, 2009·International Psychogeriatrics·Guk-Hee Suh
Jan 28, 2012·Schizophrenia Bulletin·Chian-Jue KuoChiao-Chicy Chen
Oct 5, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Kristina StarI Ralph Edwards
Nov 29, 2014·Expert Opinion on Drug Safety·Giovanni GambassiGianluca Trifirò
Oct 9, 2015·Pharmacoepidemiology and Drug Safety·Sandhya MehtaChristie Teigland
Apr 25, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Linda Simoni-WastilaLirong Zhao
Jul 19, 2008·Alimentary Pharmacology & Therapeutics·C ChristiansenH T Sorensen
Aug 21, 2014·Journal of Psychosomatic Research·Dimitry S DavydowWayne J Katon
Nov 4, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gianluca TrifiròGiovanni Gambassi
Mar 31, 2007·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Meg Voelker, Terri G Foster
Aug 10, 2007·The Australian and New Zealand Journal of Psychiatry·Jean HollisDavid Grayson
Sep 11, 2018·Expert Opinion on Drug Safety·Adamantia LiapikouAntoni Torres
Oct 20, 2018·Journal of Psychopharmacology·O DzahiniP M Haddad
Aug 11, 2017·Journal of Clinical Psychopharmacology·Arduino A MangoniRichard J Woodman
Apr 4, 2013·The Annals of Pharmacotherapy·Rajender R AparasuHua Chen
Jan 1, 2014·Health Psychology and Behavioral Medicine·Kan-Yuan ChengShu-Yuan Chen
Nov 14, 2019·ERJ Open Research·Zachary BoivinEric M Mortensen
Oct 9, 2021·Pharmacoepidemiology and Drug Safety·Marc SimardCaroline Sirois

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of the American Geriatrics Society
W KnolA C G Egberts
Pharmacoepidemiology and Drug Safety
Gianluca TrifiròMiriam C J M Sturkenboom
© 2022 Meta ULC. All rights reserved